EHU018121
MISSION® esiRNA
targeting human FOXF2
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ACTCGCTGGAGCAGAGCTACTTGCACCAGAACGCTCGCGAGGACCTCTCAGTGGGACTGCCCCGTTACCAGCATCACTCTACTCCAGTGTGTGACAGAAAAGATTTCGTCCTCAACTTCAATGGGATTTCTTCTTTCCATCCCTCAGCTAGCGGGTCGTATTATCACCATCACCACCAGAGCGTCTGTCAGGATATTAAGCCCTGCGTCATGTGAACGGAAAGAGGCCAAGCGATGGCCGCTCTCTCCTCTCCCCTCCTCAGAGGGGGCAGATAGAAACTGGGACGGATTCAAGTCACATGCACGCGGATAGCAGTAAGCCACACACCTGCCACTTAGCCAGAATGCCCAGGATCGCGTTGGTCACTGTTATTTGCCTACTGCTGGAAGAAGGACAACCGCTGGCAAGGTAGCGTTCCCCAATCT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... FOXF2(2295)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Akira Higashimori et al.
Cancer research, 78(7), 1643-1656 (2018-01-28)
DNA methylation has been identified as a hallmark of gastric cancer (GC). Identifying genes that are repressed by DNA promoter methylation is essential in providing insights into the molecular pathogenesis of gastric cancer. Using genome-wide methylation studies, we identified that
De-Zhi Zheng et al.
Immunopharmacology and immunotoxicology, 40(5), 408-414 (2018-11-30)
To reveal other miR-130b-mediated signaling pathway in the involvement of wear particle-induced inflammation and osteolysis. Particle-induced osteolysis (PIO) mice model was established. Secretion levels of TNF-α, IL-1β, IL-6, and IL-10 were measured by ELISA. miR-130b and forkhead box F2 (FOXF2)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU018121-20UG | 04061828566204 |
| EHU018121-50UG | 04061828330348 |